Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Retrospective Study on TACE for HCC by TANDEM and Idarubicin

NCT03349957 is registered in ClinicalTrials.gov with University Hospital, Montpellier as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03349957 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Retrospective Study on TACE for HCC by TANDEM and Idarubicin
Lead sponsor
University Hospital, Montpellier
Phase
Observational
Overall status
Completed
Start date
December 1, 2017
Completion date
March 30, 2018
Enrollment
98 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepatocellular carcinoma (hcc)